Shuttle Pharmaceuticals corrects pre-funded warrants issued to 9,741,751 shares as of Sept. 9

• Shuttle Pharmaceuticals amended a Sept. 15 Form 8-K to correct its disclosure on pre-funded warrants issued under Item 3.02.
• The earlier filing cited up to 16,932,508 pre-funded warrants, representing the maximum that could be issued if all conditions were met.
• As of Sept. 9, 2026, the company reported 9,741,751 pre-funded warrants had actually been issued.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-044106), on September 24, 2026, and is solely responsible for the information contained therein.